Regulation of microRNAs in coronary atherosclerotic plaque.

October 09, 2019 By:
  • Berkan O
  • Arslan S
  • Lalem T
  • Zhang L
  • Sahin NO
  • Aydemir EI
  • Korkmaz O
  • Egilmez HR
  • Cekin N
  • Devaux Y.

Aim: Identification of microRNAs (miRNAs) associated with atherosclerosis may unravel novel therapeutic targets and biomarkers. We studied miRNAs differentially expressed between coronary atherosclerotic plaques (CAP) and healthy arteries. Materials & methods: Paired CAP and internal mammary arteries (IMA) were collected from 14 coronary artery disease patients. The miRNA profiles between diseased (CAP) and healthy (IMA) tissues were compared using microarrays and quantitative PCR. Results: Thirty-one miRNAs were differentially expressed between CAP and IMA. Among these, miR-486-5p showed a high level of regulation (12-fold), had predicted interactions with atherosclerosis-associated genes and correlated with triglyceride levels and arterial stenosis. Regulation of miR-486-5p was validated by PCR (p = 0.004). Conclusion: The miRNAs are regulated in the atherosclerotic plaque. We highlight miR-486-5p whose role in atherosclerosis requires further investigation.

2019 Oct. Epigenomics.11(12):1387-1397. Epub 2019 Oct 9.
Other information